Mustafa Özdoğan

3.2k total citations
106 papers, 1.9k citations indexed

About

Mustafa Özdoğan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mustafa Özdoğan has authored 106 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Mustafa Özdoğan's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Diagnosis and Treatment (6 papers). Mustafa Özdoğan is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Diagnosis and Treatment (6 papers). Mustafa Özdoğan collaborates with scholars based in Türkiye, United Kingdom and Greece. Mustafa Özdoğan's co-authors include Erkan Çoban, G. Yazicioglu, Ayşen Timurağaoğlu, Burhan Savaş, Hakan Bozcuk, Mehmet Artaç, Mustafa Samur, Erdinç Nayır, Hakan Bozcuk and Hasan Mutlu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Mustafa Özdoğan

100 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mustafa Özdoğan Türkiye 24 736 317 292 251 247 106 1.9k
Paul Carter United Kingdom 22 473 0.6× 275 0.9× 130 0.4× 197 0.8× 165 0.7× 35 1.7k
Pilar Díz Spain 22 602 0.8× 608 1.9× 253 0.9× 295 1.2× 252 1.0× 92 2.5k
Rikje Ruiter Netherlands 26 626 0.9× 607 1.9× 384 1.3× 273 1.1× 198 0.8× 59 2.0k
Francesca Martini Italy 27 487 0.7× 370 1.2× 118 0.4× 363 1.4× 339 1.4× 78 2.2k
Olufemi J. Ogunbiyi Nigeria 19 456 0.6× 227 0.7× 196 0.7× 324 1.3× 257 1.0× 70 1.8k
V. Beral United Kingdom 15 490 0.7× 147 0.5× 269 0.9× 344 1.4× 194 0.8× 21 1.7k
David S. López United States 20 595 0.8× 652 2.1× 524 1.8× 214 0.9× 227 0.9× 80 2.1k
Egidio Celentano Italy 26 310 0.4× 275 0.9× 265 0.9× 316 1.3× 469 1.9× 83 2.1k
Fangjian Guo United States 20 284 0.4× 351 1.1× 254 0.9× 467 1.9× 365 1.5× 55 1.8k
Ji Eun Yun South Korea 23 272 0.4× 353 1.1× 243 0.8× 584 2.3× 449 1.8× 64 1.8k

Countries citing papers authored by Mustafa Özdoğan

Since Specialization
Citations

This map shows the geographic impact of Mustafa Özdoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Özdoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Özdoğan more than expected).

Fields of papers citing papers by Mustafa Özdoğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Özdoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Özdoğan. The network helps show where Mustafa Özdoğan may publish in the future.

Co-authorship network of co-authors of Mustafa Özdoğan

This figure shows the co-authorship network connecting the top 25 collaborators of Mustafa Özdoğan. A scholar is included among the top collaborators of Mustafa Özdoğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustafa Özdoğan. Mustafa Özdoğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Uras, Cihan, Mahmut Çerkez Ergören, Cemil Bilir, et al.. (2025). P044: Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey. The Breast. 80. 103928–103928.
3.
Özdoğan, Mustafa, et al.. (2024). Case report: Immunotherapy guided by molecular profiling of tumors: illustrative cases and literature review. Frontiers in Medicine. 11. 1403056–1403056. 1 indexed citations
4.
Αγιαννιτόπουλος, Κωνσταντίνος, Georgios Tsaousis, Mustafa Özdoğan, et al.. (2023). Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes.. Journal of Clinical Oncology. 41(16_suppl). e16276–e16276. 1 indexed citations
5.
Mutlu, Hasan, et al.. (2015). Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer. Journal of Cancer Research and Therapeutics. 11(2). 287–287. 5 indexed citations
6.
Taştekin, Didem, et al.. (2015). Dietary and Demographical Risk Factors for Oesophageal Squamous Cell Carcinoma in the Eastern Anatolian Region of Turkey Where Upper Gastrointestinal Cancers are Endemic. Asian Pacific Journal of Cancer Prevention. 16(5). 1913–1917. 16 indexed citations
7.
Uysal, Mükremın, et al.. (2015). Retrospective analysis of third-line chemotherapy in advanced non-small cell lung cancer. Journal of Cancer Research and Therapeutics. 11(4). 805–809. 4 indexed citations
8.
Uysal, Mükremın, et al.. (2014). The importance of COX-2 expression as prognostic factor in early breast cancer.. PubMed. 18(3). 579–84. 12 indexed citations
9.
10.
11.
Yıldız, Fahrettin, Alpaslan Terzi, Sacit Çoban, et al.. (2009). Purified Micronized Flavonoid Fraction Ameliorates the Injury of Spleen and Ileum Secondary to Hepatic Ischemia–Reperfusion in Rats. Digestive Diseases and Sciences. 55(8). 2237–2243. 9 indexed citations
12.
Yıldız, Fahrettin, Alpaslan Terzi, Hakim Çelık, et al.. (2009). Protective effects of resveratrol on small intestines against intestinal ischemia–reperfusion injury in rats. Journal of Gastroenterology and Hepatology. 24(11). 1781–1785. 24 indexed citations
13.
Bozcuk, Hakan, Durmuş Burgucu, Deniz Ekinci, et al.. (2007). Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: Preliminary results of an in vitro study. Cell Biology International. 31(9). 1069–1071. 34 indexed citations
14.
Bozcuk, Hakan, Aziz Gümüş, Gülay Özbilim, et al.. (2005). Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.. PubMed. 11(6). HY11–20. 7 indexed citations
15.
Çoban, Erkan, et al.. (2005). The mean platelet volume in patients with obesity. International Journal of Clinical Practice. 59(8). 981–982. 234 indexed citations
16.
Çoban, Erkan & Mustafa Özdoğan. (2004). The plasma levels of plasminogen activator inhibitor-1 in subjects with white coat hypertension. International Journal of Clinical Practice. 58(6). 541–544. 9 indexed citations
17.
Bozcuk, Hakan, Mustafa Samur, Mustafa Özdoğan, et al.. (2004). A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients. International Journal of Clinical Practice. 58(11). 1014–1019. 33 indexed citations
18.
Samur, Mustafa, Şeyda Karaveli, Hakan Bozcuk, et al.. (2003). A Novel Method of Reporting c-erbB-2 Overexpression: Correlation with Grade But Not with Other Prognostic Parameters in Breast Cancer*. TURKISH JOURNAL OF MEDICAL SCIENCES. 33(6). 363–368. 2 indexed citations
19.
Özdoğan, Mustafa. (2003). Durable Remission of Leptomeningeal Metastasis of Breast Cancer with Letrozole: a Case Report and Implications of Biomarkers on Treatment Selection. Japanese Journal of Clinical Oncology. 33(5). 229–231. 36 indexed citations
20.
Bozcuk, Hakan, Elif Peştereli, Mustafa Samur, et al.. (2001). Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators. Breast Cancer Research and Treatment. 68(3). 239–248. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Carter Breakdown of academic impact, for papers by Pilar Díz Breakdown of academic impact, for papers by Rikje Ruiter Breakdown of academic impact, for papers by Francesca Martini Breakdown of academic impact, for papers by Olufemi J. Ogunbiyi Breakdown of academic impact, for papers by V. Beral Breakdown of academic impact, for papers by David S. López Breakdown of academic impact, for papers by Egidio Celentano Breakdown of academic impact, for papers by Fangjian Guo Breakdown of academic impact, for papers by Ji Eun Yun
Rankless by CCL
2026